bioAffinity Technologies (BIAF) Retained Earnings (2022 - 2025)
bioAffinity Technologies (BIAF) has disclosed Retained Earnings for 4 consecutive years, with -$65.4 million as the latest value for Q3 2025.
- On a quarterly basis, Retained Earnings fell 28.99% to -$65.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$65.4 million, a 28.99% decrease, with the full-year FY2024 number at -$53.6 million, down 20.27% from a year prior.
- Retained Earnings was -$65.4 million for Q3 2025 at bioAffinity Technologies, down from -$60.4 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$35.0 million in Q3 2022 to a low of -$65.4 million in Q3 2025.
- A 4-year average of -$47.6 million and a median of -$46.6 million in 2024 define the central range for Retained Earnings.
- Peak YoY movement for Retained Earnings: decreased 20.14% in 2024, then fell 28.99% in 2025.
- bioAffinity Technologies' Retained Earnings stood at -$36.7 million in 2022, then fell by 21.65% to -$44.6 million in 2023, then dropped by 20.27% to -$53.6 million in 2024, then fell by 21.91% to -$65.4 million in 2025.
- Per Business Quant, the three most recent readings for BIAF's Retained Earnings are -$65.4 million (Q3 2025), -$60.4 million (Q2 2025), and -$56.3 million (Q1 2025).